Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, September 30, 2021
FUJIFILM Irvine Scientific, Inc., announced that it completed construction and started the commissioning phase of its new manufacturing facility in Tilburg, the Netherlands. The commissioning milestone marks the beginning of validating the facility ...
read more
FUJIFILM Irvine Scientific announced plans to open a third manufacturing facility located in Tilburg, Netherlands.
read more
Tuesday, November 22, 2022
FUJIFILM Corporation announced a $188 million investment to establish a cell culture media manufacturing facility in Research Triangle Park (RTP), North Carolina, USA. The new site will be operated by FUJIFILM Irvine Scientific,
read more
Fujifilm Diosynth Biotechnologies has announced the reduction of cell line development timelines with its Apollo X™ Advanced Mammalian Expression System.
read more
FUJIFILM announced an initial $10M USD investment to establish a full scale, fully integrated continuous processing facility for non-GMP manufacture of biopharmaceuticals at its Billingham, UK location.
read more
Monday, November 06, 2017
FUJIFILM is to invest a total of 3.2 billion yen on its CDMO sites in the U.S. and the U.K. in order to accelerate the expansion of the company's business for developing and manufacturing biopharmaceuticals under contract for other parties.
read more
Wednesday, April 26, 2017
Fujifilm Corporation will increase production capacity by investing approximately $130 million in the United States and UK to expand the business of its BioCDMO Division.
read more
FUJIFILM Diosynth Biotechnologies U.S.A., Inc., a Biologics Contract Development and Manufacturing Organization with experience focused on the development and manufacture of recombinant biopharmaceuticals including proteins, vaccines, and monoclonal ...
read more
FUJIFILM Diosynth Biotechnologies has commenced the planned capacity expansion of its Flexible Biomanufacturing Facility at its College Station, Texas location.
read more
Wednesday, August 27, 2014
FUJIFILM Diosynth Biotechnologies has announced continued expansion of its cell culture manufacturing capabilities with the addition of two 2000L single-use bioreactors. One each of these is being installed at the company's sites in Research Triangle...
read more
FUJIFILM Diosynth Biotechnologies has announced an expansion to its United Kingdom location through the creation of a new BioCampus.
read more
Thursday, August 01, 2019
FUJIFILM has completed the acquisition of Biogen (Denmark) Manufacturing ApS, a large-scale biologics manufacturing site located in Hillerød near Copenhagen, Denmark from Biogen.
read more
Friday, September 05, 2025
FUJIFILM Biotechnologies announced the appointment of Samuel Hernandez, Ph.D., as senior vice president and site head for its College Station, Texas facility. With over two decades of biotechnology and pharmaceutical leadership experience, Dr. ...
read more
FUJIFILM Biotechnologies has launched ShunzymeX precision purification technology, which simplifies downstream processing for complex biologics
read more
Fujifilm has announced the extension of its gene therapy and viral vaccine Fill/Finish capabilities to provide services in support of late phase candidates and commercial supply.
read more